The National Scientific Committee for the Management and Control of Sheep and Goat Pox in Greece has published a report that assesses the findings of a European Food Safety Authority (EFSA) report concerning vaccination strategies against sheep and goat pox (SGP) in Greece and Bulgaria, projected for 2025. The EFSA's report, released on February 4, 2026, outlines the current knowledge about SGP vaccines and the various vaccination scenarios proposed to mitigate outbreaks in these countries.

The findings from the Greek committee highlight critical concerns regarding the feasibility of widespread vaccination in Greece at this stage. Although the EFSA report contributes significantly to understanding the disease and potential vaccination methods, there are notable uncertainties and limitations. The lack of approved vaccines within the EU, insufficient DIVA capabilities, and limited effectiveness data pose substantial challenges that render broad vaccination initiatives both scientifically and operationally unsafe at this time.

As the situation remains precarious, the report emphasizes the need for further research and the establishment of reliable vaccination strategies before implementing any large-scale vaccination programs against sheep and goat pox. The ongoing dialogue among European scientists and policymakers will be crucial to addressing these issues and ensuring effective control of the disease in the coming years.